Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionbubble DNA binding

ABL1 RECQL4

2.46e-048602GO:0000405
GeneOntologyMolecularFunctionDNA secondary structure binding

ABL1 RECQL4 KMT2A

2.53e-0441603GO:0000217
GeneOntologyBiologicalProcesshemopoiesis

DOCK1 BCL11B ABL1 SH3PXD2A PRRC2C PLA2G3 SHB SIGLEC10 BLNK APC KMT2A KLF3 MED1 PRG4

6.62e-0612235914GO:0030097
GeneOntologyCellularComponentribbon synapse

AMPH PCLO ATP2B1

1.05e-0432603GO:0097470
DomainSH3

DOCK1 AMPH MYO15B ABL1 SH3PXD2A CASKIN1 SRGAP2 FNBP1L SH3BP4

2.78e-08216609SM00326
DomainSH3

DOCK1 AMPH MYO15B ABL1 SH3PXD2A CASKIN1 SRGAP2 FNBP1L SH3BP4

2.78e-08216609PS50002
DomainSH3_domain

DOCK1 AMPH MYO15B ABL1 SH3PXD2A CASKIN1 SRGAP2 FNBP1L SH3BP4

3.25e-08220609IPR001452
DomainSH3_1

DOCK1 AMPH ABL1 SH3PXD2A SRGAP2 FNBP1L SH3BP4

9.25e-07164607PF00018
DomainSH3_2

AMPH MYO15B CASKIN1 SH3BP4

1.68e-0486604IPR011511
DomainSH3_2

AMPH MYO15B CASKIN1 SH3BP4

1.68e-0486604PF07653
DomainuDENN

DENND2A DENND2B

9.01e-0414602SM00800
DomainuDENN

DENND2A DENND2B

1.04e-0315602PF03456
DomainUDENN

DENND2A DENND2B

1.18e-0316602PS50946
DomainDDENN

DENND2A DENND2B

1.18e-0316602PS50947
DomainDENN

DENND2A DENND2B

1.18e-0316602SM00799
DomaindDENN

DENND2A DENND2B

1.18e-0316602SM00801
DomainDENN

DENND2A DENND2B

1.18e-0316602PF02141
DomaindDENN_dom

DENND2A DENND2B

1.18e-0316602IPR005112
DomainuDENN_dom

DENND2A DENND2B

1.18e-0316602IPR005113
DomaindDENN

DENND2A DENND2B

1.18e-0316602PF03455
DomainDENN

DENND2A DENND2B

1.18e-0316602PS50211
DomainDENN_dom

DENND2A DENND2B

1.18e-0316602IPR001194
DomainFCH

SRGAP2 FNBP1L

2.25e-0322602PF00611
DomainFCH

SRGAP2 FNBP1L

2.25e-0322602SM00055
DomainFCH_dom

SRGAP2 FNBP1L

2.46e-0323602IPR001060
DomainF_BAR

SRGAP2 FNBP1L

2.90e-0325602IPR031160
DomainF_BAR

SRGAP2 FNBP1L

2.90e-0325602PS51741
DomainSH2

ABL1 SHB BLNK

4.20e-03101603PF00017
DomainSH2

ABL1 SHB BLNK

5.33e-03110603SM00252
DomainSH2

ABL1 SHB BLNK

5.47e-03111603PS50001
DomainSH2

ABL1 SHB BLNK

5.60e-03112603IPR000980
Domain-

ABL1 SHB BLNK

5.60e-031126033.30.505.10
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

MICALL1 SRRM1 ABL1 TTC28 KIF26B SH3PXD2A PRRC2C APC KMT2A CC2D1A SRGAP2 CCDC6 ATP2B1 DENND2B MEX3B SH3BP4

1.64e-12861621636931259
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

MICALL1 USP36 ATAD5 SH3PXD2A PRRC2C APC CC2D1A SRGAP2 FNBP1L MED1 NOP2

5.72e-08724621136232890
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

DOCK1 SRRM1 APC TNIP1 CC2D1A MED1 CCDC6 NOP2 SH3BP4

2.65e-0750362916964243
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

DOCK1 PMS2P2 TNRC18 SH3PXD2A SHB BLNK SRGAP2 FNBP1L PRKAG2 ATP2B1 DENND2B PPP1CB SH3BP4

1.80e-061489621328611215
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

SRRM1 SGIP1 SH3PXD2A CASKIN1 PCLO APC FNBP1L

2.85e-0634762717114649
Pubmed

Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome.

RECQL4 APC

3.13e-06262215703196
Pubmed

Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli.

ABL1 SHB

3.13e-06262217112510
Pubmed

Group III phospholipase A2 promotes colitis and colorectal cancer.

PLA2G3 APC

3.13e-06262228947740
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

MICALL1 DOCK1 NUP155 TTC28 PRRC2C SHB APC CC2D1A ATP2B1

4.42e-0670862939231216
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

DENND2A AMPH SGIP1 PRRC2C CASKIN1 PCLO APC KMT2A SRGAP2 PRKAG2 ATP2B1 PPP1CB

7.21e-061431621237142655
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

BCL11B SGIP1 PRRC2C CASKIN1 APC SRGAP2 CCDC6 NOP2 ATF6B PPP1CB

7.38e-06963621028671696
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

GARIN5B SRRM1 TNRC18 SH3PXD2A PRRC2C PCLO SHB KMT2A FNBP1L NDUFA7 ATP2B1 PPP1CB

7.79e-061442621235575683
Pubmed

SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization.

APC SH3BP4

9.37e-06362230811977
Pubmed

Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.

BCL11B APC

9.37e-06362225827435
Pubmed

Comparison of the fertility of tumor suppressor gene-deficient C57BL/6 mouse strains reveals stable reproductive aging and novel pleiotropic gene.

RECQL4 APC

9.37e-06362234117297
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

USP36 SRRM1 BCL11B ATAD5 PRRC2C KMT2A NOP2 PPP1CB

1.19e-0560562828977666
Pubmed

LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.

MYO15B PRRC2C PCLO APC KMT2A SRGAP2 CCDC6 NOP2

1.76e-0563962823443559
Pubmed

Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.

ABL1 KMT2A

1.87e-05462234048072
Pubmed

Activation of extracellular signal-regulated kinase 2 by a novel Abl-binding protein, ST5.

ABL1 DENND2B

1.87e-0546229632734
Pubmed

A genome-wide association study of monozygotic twin-pairs suggests a locus related to variability of serum high-density lipoprotein cholesterol.

DOCK1 SRGAP2

1.87e-05462223031429
Pubmed

Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated pits.

AMPH SGIP1

1.87e-05462220946875
Pubmed

An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth.

ABL1 APC

1.87e-05462225834110
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

NUP155 TTC28 PRRC2C RECQL4 NACA APC KMT2A SH3BP4

1.98e-0565062838777146
Pubmed

Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2rI1565A) results in partial lethality, overgrowth and intestinal adenoma progression.

BCL11B APC

3.12e-05562231388182
Pubmed

Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK.

DOCK1 ABL1

3.12e-05562217515907
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

TTC28 KIF26B APC CCDC6 PPP1CB

3.66e-0520962536779422
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

USP36 ATAD5 PRRC2C NACA KMT2A CC2D1A SRGAP2 MED1 NOP2

3.96e-0593462933916271
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

PRRC2C NACA APC CC2D1A SRGAP2 CCDC6

4.45e-0536062633111431
Pubmed

The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.

ABL1 KMT2A

4.67e-05662216386788
Pubmed

Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.

BLNK KMT2A

4.67e-05662225759025
Pubmed

Proapoptotic function of the nuclear Crk II adaptor protein.

DOCK1 ABL1

4.67e-05662217764157
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

MICALL1 SRRM1 NUP155 ATAD5 TNIP1 CC2D1A NDUFA7 NOP2 ATP2B1 ATF6B SH3BP4

5.74e-051487621133957083
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

MICALL1 KIF26B SHB SRGAP2 ATP2B1 SH3BP4

5.75e-0537762638117590
Pubmed

Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

ABL1 APC

6.53e-05762217318191
Pubmed

Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.

KMT2A MED1

6.53e-05762229997176
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

MICALL1 SRRM1 KMT2A MED1 CCDC6 NOP2 PRG4 PPP1CB

6.80e-0577462815302935
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

USP36 SRRM1 NUP155 TTC28 APC CC2D1A NOP2 SH3BP4

6.98e-0577762835844135
Pubmed

C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.

DOCK1 ABL1

8.69e-05862215700267
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

SRRM1 TTC28 ATAD5 KMT2A MED1 NOP2 PPP1CB

1.48e-0464562725281560
Pubmed

SIP1 expression patterns in brain investigated by generating a SIP1-EGFP reporter knock-in mouse.

BCL11B APC

1.70e-041162224243579
Pubmed

Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.

TNIP1 CC2D1A PPP1CB

1.72e-046062334761192
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

AMPH TNRC18 SGIP1 PRRC2C CASKIN1 PCLO NACA APC PPP1CB

1.79e-04113962936417873
Pubmed

Ulk4 Regulates Neural Stem Cell Pool.

BCL11B APC

2.04e-041262227300315
Pubmed

Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.

DENND2A SGIP1 SRGAP2

2.38e-046762329254152
Pubmed

The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.

APC KMT2A

2.41e-041362216510874
Pubmed

EHBP1L1 coordinates Rab8 and Bin1 to regulate apical-directed transport in polarized epithelial cells.

MICALL1 AMPH

2.41e-041362226833786
Pubmed

BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.

USP36 NUP155 NACA KMT2A FNBP1L NOP2 PPP1CB

2.69e-0471162733022573
Pubmed

Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.

ABL1 SRGAP2

2.81e-04146228605874
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

USP36 SRRM1 ATAD5 PRRC2C KMT2A MED1 C2orf49 NOP2

2.84e-0495462836373674
Pubmed

Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.

ABL1 SHB BLNK

3.07e-047362324728074
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

SRRM1 NPPC NUP155 PRRC2C NACA NOP2 ATP2B1 PPP1CB

3.19e-0497162833306668
Pubmed

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

APC KMT2A

3.23e-041562216510875
Pubmed

Abl family tyrosine kinases are essential for basement membrane integrity and cortical lamination in the cerebellum.

BCL11B ABL1

3.23e-041562220980600
Pubmed

Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.

ABL1 SHB BLNK

3.59e-047762322973453
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MICALL1 USP36 DENND2A NUP155 CASKIN1 NACA

3.60e-0452962614621295
Pubmed

Partial transcriptome of the developing pituitary gland.

AMPH APC

3.69e-041662211161784
Pubmed

Kif26b, a kinesin family gene, regulates adhesion of the embryonic kidney mesenchyme.

KIF26B NPNT

3.69e-041662220439720
Pubmed

Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype.

BCL11B APC

4.18e-041762233976153
Pubmed

Fstl1 is involved in the regulation of radial glial scaffold development.

BCL11B APC

4.18e-041762226382033
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

TTC28 PRRC2C KMT2A TNIP1 CC2D1A MED1

4.38e-0454962638280479
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

SRRM1 APC CCDC6 NOP2 PPP1CB

4.67e-0436162530344098
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

PRRC2C KMT2A NOP2 ATP2B1

4.73e-0420262424639526
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

MICALL1 SHB CC2D1A SRGAP2 FNBP1L ATP2B1

5.09e-0456562625468996
Pubmed

Tle4 controls both developmental acquisition and early post-natal maturation of corticothalamic projection neuron identity.

BCL11B SHB

5.24e-041962237561632
Pubmed

An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.

KMT2A MED1

5.24e-041962216799563
Pubmed

APC sets the Wnt tone necessary for cerebral cortical progenitor development.

BCL11B APC

5.24e-041962228916710
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

MICALL1 EAF1 SH3PXD2A PCARE POLL SRGAP2 MED1 PPP1CB SH3BP4

5.30e-04132162927173435
Pubmed

Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.

BCL11B APC

5.82e-042062232294449
Pubmed

The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation.

BCL11B APC

5.82e-042062222542597
Pubmed

Differential regulation of microtubule severing by APC underlies distinct patterns of projection neuron and interneuron migration.

BCL11B APC

5.82e-042062225535916
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

TTC28 PRRC2C APC TNIP1 FNBP1L CCDC6

6.27e-0458862638580884
Pubmed

Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.

DOCK1 PRRC2C SIGLEC10

6.64e-049562324029230
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

SRRM1 PRRC2C NACA KMT2A CC2D1A MED1 C2orf49 NOP2 PPP1CB

6.92e-04137162936244648
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

SRRM1 ATAD5 KMT2A MED1 PPP1CB

6.93e-0439462527248496
Pubmed

PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA.

PRRC2C APC

7.06e-042262238507412
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

TNRC18 PRRC2C KMT2A CC2D1A MED1 C2orf49 NOP2 MNT

7.40e-04110362834189442
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MICALL1 TNRC18 ABL1 CASKIN1 CC2D1A POLL SRGAP2 SH3BP4

7.49e-04110562835748872
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

NUP155 PRRC2C RECQL4 NACA NOP2 PPP1CB

7.92e-0461562631048545
Pubmed

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

APC DENND2B SH3BP4

8.17e-0410262315778465
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

SRRM1 BCL11B KMT2A

8.40e-0410362332744500
Pubmed

Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.

ABL1 SHB

8.41e-042462220624904
Pubmed

Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions.

SH3PXD2A FNBP1L

8.41e-042462225825872
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

SRRM1 NUP155 PRRC2C NACA CC2D1A SRGAP2 FNBP1L NOP2 PPP1CB

8.65e-04141562928515276
Pubmed

Human transcription factor protein interaction networks.

ATAD5 PRRC2C NACA KMT2A KLF3 TNIP1 CC2D1A NOP2 MNT

9.27e-04142962935140242
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

ATAD5 PRRC2C NACA APC

9.30e-0424262434011540
Pubmed

Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

MICALL1 SRRM1 ABL1

9.64e-0410862319531213
Pubmed

Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.

SRRM1 DENND2A PCLO NACA KMT2A

9.72e-0442562524999758
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

DOCK1 TNRC18 NUP155 MEX3B SH3BP4

1.02e-0343062535044719
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

SRRM1 SGIP1 CASKIN1 APC ATP2B1

1.02e-0343062532581705
Pubmed

Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.

SRRM1 PRRC2C KMT2A PRKAG2 NOP2

1.05e-0343262523455922
Pubmed

Bulk and mosaic deletions of Egfr reveal regionally defined gliogenesis in the developing mouse forebrain.

BCL11B APC

1.07e-032762236915679
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

SRRM1 NUP155 PRRC2C KMT2A NOP2 PPP1CB

1.08e-0365362622586326
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

MICALL1 SRRM1 SRGAP2 SH3BP4

1.13e-0325562415324660
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

NUP155 APC MED1 CCDC6 NOP2

1.13e-0344062534244565
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

SRRM1 NUP155 NACA SRGAP2 NOP2 PPP1CB

1.14e-0366062632780723
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

KIF26B PRRC2C NACA APC

1.14e-0325662433397691
Pubmed

Novel interactors and a role for supervillin in early cytokinesis.

SH3PXD2A KMT2A

1.15e-032862220309963
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

SRRM1 ABL1 SH3PXD2A KMT2A CCDC6 PRKAG2 PPP1CB

1.16e-0391062736736316
Pubmed

SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.

USP36 SRRM1 MED1 NOP2

1.19e-0325962430404004
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

DOCK1 SRRM1 SH3PXD2A NACA KMT2A SRGAP2 CCDC6

1.20e-0391662732203420
InteractionYWHAH interactions

MICALL1 SRRM1 ABL1 TTC28 KIF26B SH3PXD2A PRRC2C RECQL4 APC KMT2A CC2D1A SRGAP2 MED1 CCDC6 DENND2B MEX3B SH3BP4

1.69e-0811026117int:YWHAH
InteractionDENND2B interactions

DENND2A ABL1 TNIP1 DENND2B PPP1CB

2.00e-0828615int:DENND2B
InteractionYWHAG interactions

MICALL1 SRRM1 ABL1 TTC28 KIF26B SH3PXD2A PRRC2C RECQL4 SHB APC KMT2A SRGAP2 CCDC6 C2orf49 DENND2B MEX3B SH3BP4

1.03e-0712486117int:YWHAG
InteractionYWHAZ interactions

MICALL1 ABL1 TTC28 KIF26B SH3PXD2A RECQL4 APC KMT2A TNIP1 SRGAP2 CCDC6 C2orf49 ATP2B1 DENND2B MEX3B SH3BP4

1.27e-0613196116int:YWHAZ
InteractionAP2A1 interactions

USP36 AMPH ABL1 SGIP1 RECQL4 TNIP1 MEX3B PPP1CB

3.18e-06299618int:AP2A1
InteractionYWHAE interactions

MICALL1 ABL1 TTC28 KIF26B SH3PXD2A RECQL4 APC KMT2A TNIP1 SRGAP2 CCDC6 C2orf49 DENND2B MEX3B SH3BP4

3.56e-0612566115int:YWHAE
InteractionYWHAB interactions

MICALL1 ABL1 TTC28 KIF26B SH3PXD2A RECQL4 APC KMT2A SRGAP2 CCDC6 DENND2B MEX3B SH3BP4

8.47e-0610146113int:YWHAB
InteractionKCNA3 interactions

MICALL1 DOCK1 SRRM1 NUP155 TTC28 PRRC2C NACA SHB APC KMT2A CC2D1A ATP2B1

9.72e-068716112int:KCNA3
InteractionZNF638 interactions

USP36 SRRM1 SH3PXD2A RECQL4 SRGAP2 PPP1CB SH3BP4

1.35e-05261617int:ZNF638
InteractionNCK2 interactions

DOCK1 PRR16 TTC28 SHB BLNK CCDC6 MNT

1.39e-05262617int:NCK2
InteractionAP2B1 interactions

USP36 AMPH ABL1 SGIP1 RECQL4 APC TNIP1 MEX3B

1.60e-05373618int:AP2B1
InteractionENTR1 interactions

NUP155 RECQL4 TNIP1 CC2D1A CCDC6 PRKAG2

2.21e-05188616int:ENTR1
InteractionYWHAQ interactions

ABL1 TTC28 KIF26B SH3PXD2A RECQL4 APC KMT2A SRGAP2 MED1 CCDC6 C2orf49 DENND2B SH3BP4

2.39e-0511186113int:YWHAQ
InteractionSFN interactions

ABL1 KIF26B SH3PXD2A PRRC2C RECQL4 APC KMT2A SRGAP2 DENND2B SH3BP4

3.95e-056926110int:SFN
InteractionAP2S1 interactions

AMPH SGIP1 RECQL4 NACA APC

4.60e-05130615int:AP2S1
InteractionH2BC12 interactions

USP36 SRRM1 TNRC18 PCLO KMT2A TNIP1 NOP2

5.19e-05322617int:H2BC12
InteractionNOLC1 interactions

USP36 SRRM1 EAF1 APC TNIP1 CC2D1A NOP2

5.50e-05325617int:NOLC1
InteractionH3C1 interactions

USP36 GARIN5B TNRC18 ATAD5 PRRC2C NACA KMT2A TNIP1 CCDC6 NOP2 PPP1CB

7.22e-059016111int:H3C1
InteractionCHD3 interactions

USP36 SRRM1 BCL11B ATAD5 PRRC2C RECQL4 KMT2A KLF3 NOP2 PPP1CB

8.38e-057576110int:CHD3
InteractionEIF2S3B interactions

RECQL4 TNIP1 NOP2

9.12e-0529613int:EIF2S3B
InteractionCSNK2A1 interactions

SRRM1 TTBK2 ATAD5 PRRC2C RECQL4 NACA APC KMT2A SRGAP2 CCDC6 ATP2B1

1.22e-049566111int:CSNK2A1
InteractionPFN1 interactions

DOCK1 USP36 PCLO RECQL4 APC TNIP1 SRGAP2 CCDC6

1.42e-04509618int:PFN1
InteractionCALD1 interactions

SRRM1 PRRC2C KMT2A TNIP1 SRGAP2 PPP1CB

1.48e-04265616int:CALD1
InteractionSPECC1L interactions

RECQL4 NACA APC TNIP1 PPP1CB

1.50e-04167615int:SPECC1L
InteractionHECTD1 interactions

NUP155 TTC28 ATAD5 SH3PXD2A PRRC2C RECQL4 NACA APC SRGAP2 MED1 NOP2

1.58e-049846111int:HECTD1
InteractionGRWD1 interactions

USP36 RECQL4 NACA KMT2A TNIP1 NOP2 PPP1CB

1.71e-04390617int:GRWD1
InteractionRHOB interactions

MICALL1 DOCK1 SGIP1 NUP155 KIF26B SHB CC2D1A ATP2B1 PPP1CB SH3BP4

1.96e-048406110int:RHOB
InteractionSSRP1 interactions

USP36 SRRM1 RECQL4 KMT2A TNIP1 POLL NOP2 ATP2B1 PPP1CB

2.05e-04685619int:SSRP1
InteractionH2BC18 interactions

GARIN5B ATAD5 PCLO SRGAP2 SH3BP4

2.13e-04180615int:H2BC18
InteractionCSDE1 interactions

GARIN5B PRRC2C RECQL4 TNIP1 CCDC6 MEX3B

2.15e-04284616int:CSDE1
InteractionUNK interactions

NUP155 PRRC2C TNIP1 CC2D1A CCDC6 ATP2B1 PPP1CB

2.25e-04408617int:UNK
InteractionKCTD13 interactions

DENND2A AMPH SGIP1 PRRC2C CASKIN1 PCLO APC KMT2A TNIP1 SRGAP2 PRKAG2 ATP2B1 PPP1CB

2.26e-0413946113int:KCTD13
InteractionGRAP2 interactions

ABL1 SHB BLNK TNIP1

2.79e-04104614int:GRAP2
InteractionAP2M1 interactions

AMPH ABL1 EAF1 SGIP1 APC TNIP1 MEX3B

3.10e-04430617int:AP2M1
InteractionDENND2A interactions

DENND2A DENND2B

3.20e-049612int:DENND2A
Cytoband5q23.1

LVRN PRR16

6.16e-04276225q23.1
CytobandEnsembl 112 genes in cytogenetic band chr2p23

PRR30 PCARE PPP1CB

1.10e-03149623chr2p23
CytobandEnsembl 112 genes in cytogenetic band chr10q24

SH3PXD2A BLNK POLL

2.17e-03189623chr10q24
CytobandEnsembl 112 genes in cytogenetic band chr2q37

COL6A3 NPPC SH3BP4

3.59e-03226623chr2q37
GeneFamilyRho GTPase activating proteins|F-BAR domain containing

SRGAP2 FNBP1L

1.11e-03233921288
GeneFamilyGuanylate cyclase receptors|DENN/MADD domain containing

DENND2A DENND2B

1.32e-0325392504
GeneFamilySH2 domain containing

ABL1 SHB BLNK

1.34e-03101393741
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PCLO CC2D1A

2.73e-0336392823
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

DOCK1 AMPH TTC28 PRRC2C SHB APC SRGAP2 FNBP1L MED1 CCDC6 ATP2B1 DENND2B MNT

8.31e-088566213M4500
CoexpressionIBRAHIM_NRF1_DOWN

TNRC18 PCLO RECQL4 KLF3 POLL SRGAP2

2.80e-06167626M42512
CoexpressionGSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN

PRR16 SH3PXD2A APC FNBP1L MED1 ATP2B1

7.45e-06198626M5701
CoexpressionCAMP_UP.V1_DN

USP36 SRRM1 MYO15B SH3PXD2A PCLO ATP2B1

7.67e-06199626M2719
CoexpressionGRESHOCK_CANCER_COPY_NUMBER_UP

BCL11B ABL1 RECQL4 NACA APC KMT2A CCDC6

1.11e-05323627M9150
CoexpressionWATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN

COL6A3 CCDC6 NOP2 MNT

7.08e-0593624M4752
CoexpressionAtlasMyeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3

DOCK1 GPR157 BLNK FNBP1L ATP2B1 DENND2B MEX3B SH3BP4

1.95e-05411608GSM538271_500
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1 TTC28 GPR157

2.71e-07194616011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PRR16 COL6A3 SGIP1 KIF26B GPR157 NPNT

2.71e-0719461635f132cc38ac133be01834ed0946188aa0757eb4
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1 TTC28 KIF26B

2.79e-07195616603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NPPC BCL11B SHB BLNK SH3BP4

2.88e-061626154d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

TNRC18 TTC28 KIF26B SH3PXD2A NPNT

5.64e-06186615de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

TNRC18 TTC28 KIF26B SH3PXD2A NPNT

5.64e-061866150b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCellIPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class

ABL1 GPR157 SIGLEC10 CCDC6 SH3BP4

5.94e-061886152331a2bae1383820d598e93aa86c75b101069bac
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 KIF26B GPR157

6.10e-061896152a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 DENND2A COL6A3 SGIP1 DENND2B

6.26e-061906154eb92aef1ee868f4537483d19014d947b7684612
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 DENND2A COL6A3 SGIP1 DENND2B

6.26e-061906157be4341e2909101d756f14031c21e705eb45e69a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 SGIP1 SH3PXD2A DENND2B

6.42e-0619161504c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 DENND2A COL6A3 SGIP1 NPNT

6.42e-061916156688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellCOPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class

ABL1 GPR157 SIGLEC10 CCDC6 SH3BP4

6.58e-06192615bd3d00b094d92463b06023361a71240851a542b8
ToppCellLPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 TTC28 KIF26B

6.58e-06192615162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 KIF26B GPR157

6.58e-06192615deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellCOPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

PRR16 COL6A3 SGIP1 KIF26B NPNT

6.58e-0619261562904f94dfce430456f05066522cbf9bd29f4d7e
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1 TTC28

6.75e-06193615e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1 TTC28

6.75e-06193615acad568621ed677031797b8c2e34dafea798d681
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1 KIF26B

6.92e-0619461503a269f75a481ea54aea8e6444605db8d6df493d
ToppCellnucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 DENND2A COL6A3 SGIP1 KIF26B

6.92e-061946152d66091097e106c7bee22e5281f50724700bdf8d
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 SGIP1 GPR157

6.92e-0619461560622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellControl-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

PRR16 COL6A3 SGIP1 PRG4 NPNT

6.92e-061946153c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRR16 COL6A3 SGIP1 PRG4 NPNT

7.10e-06195615df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PRRC2C PCLO KMT2A ATP2B1

7.10e-061956153e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PRRC2C PCLO KMT2A ATP2B1

7.10e-061956157796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

PRR16 COL6A3 SGIP1 TTC28 KIF26B

7.46e-06197615f1c8936986123a3151140c374fcd62d6705c530b
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PRR16 DENND2A COL6A3 AMPH SGIP1

7.46e-0619761544673c38384453207871d3fd8e8ba9093cc06bc5
ToppCellCOVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations)

PRR16 COL6A3 SGIP1 TTC28 KIF26B

7.46e-06197615fb847f2277609c31fffcdf49517243ce0684facf
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

PRR16 DENND2A COL6A3 SGIP1 KIF26B

7.64e-06198615df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellFetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1 TTC28

7.64e-0619861521cf4d81386761d09d0f6829c01c198e5524176d
ToppCellFetal_29-31_weeks|World / Lineage, Cell type, age group and donor

DENND2A COL6A3 SGIP1 KIF26B SH3PXD2A

7.83e-061996155b9d355795dd03a22f0961dfd143425c367a4654
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1 TTC28

7.83e-061996154bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 FGFBP2 PRG4 DENND2B

5.34e-051506141270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 FGFBP2 PRG4 DENND2B

5.34e-05150614156118ce1d69522624196410cba18b8354cd0bb4
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 PRG4 DENND2B

8.29e-05168614d19a115365c5415e51c039718d7669de788fcf33
ToppCellControl-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1

8.88e-05171614080003f698f867935c2bfc55d241d3650f45a0ab
ToppCellAdult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1

9.29e-05173614fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCellCV-Mild-6|Mild / Virus stimulation, Condition and Cluster

USP36 ABL1 EAF1 MNT

9.71e-05175614c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SHB FNBP1L CCDC6 SH3BP4

1.01e-04177614e68ad19963a3d8917dfdb81127a41c4fcbe61dd5
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A AMPH SGIP1 SH3BP4

1.04e-041786144df6218b20c2f076c22346d23260964cc0d73e65
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 SGIP1 DENND2B

1.04e-0417861478a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

DENND2A COL6A3 SGIP1 PRG4

1.06e-0417961410fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.08e-04180614280ff5c8f292be1b88120db5ff1788b750644856
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.08e-04180614fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NPPC KIF26B KLF3 PCARE

1.13e-04182614f00eec1f434d92d44787d3d3343476c98c3de5b4
ToppCell3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RECQL4 TNIP1 SRGAP2 MMACHC

1.15e-0418361491079a11685dd466bd27a0cf5afbf3734c08a05e
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NPPC BCL11B KIF26B FNBP1L

1.18e-041846142ba98708dfd7f1b2a661578a334684094ff453ad
ToppCellCOPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class

ABL1 GPR157 CCDC6 SH3BP4

1.18e-0418461442d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DENND2A COL6A3 AMPH SGIP1

1.18e-04184614102b6f621a5b551e622f97b12d787c080b052a72
ToppCellCOVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations)

PRR16 DENND2A SGIP1 DENND2B

1.20e-041856144905adaeeffd353e089578e5ea614437dbe794e6
ToppCellIPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class

ABL1 GPR157 CCDC6 SH3BP4

1.23e-04186614962c2dada19185628ead77c32fcb07fa95114247
ToppCellAdult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1

1.25e-0418761462759efb660179402fb574ce5701c89a2e17bcfe
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1

1.25e-0418761492d468dde81125d51daf7abd4703741abe1ab91c
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1

1.25e-04187614bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AMPH SH3PXD2A BLNK SH3BP4

1.28e-04188614bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCellIPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class

ABL1 GPR157 CCDC6 SH3BP4

1.28e-0418861447bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCellCOVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type

SGIP1 BLNK DENND2B SH3BP4

1.28e-04188614df1fd0819d301679f3c9ea404e942e39095912eb
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AMPH SH3PXD2A BLNK SH3BP4

1.28e-04188614eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PCARE SRGAP2 PRG4 NPNT

1.28e-041886149db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRR16 COL6A3 AMPH DENND2B

1.28e-04188614997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PCARE SRGAP2 PRG4 NPNT

1.28e-04188614047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 GPR157

1.31e-04189614a153b83314cf52808f685296cff8c95af3f4983d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A AMPH BLNK SH3BP4

1.31e-04189614977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A SGIP1 BLNK SH3BP4

1.31e-04189614975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PRR16 BCL11B FNBP1L NPNT

1.31e-04189614f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PRR16 COL6A3 GPR157 NPNT

1.31e-04189614203c80030df08ae112f9ae4043709f455d87ce89
ToppCellMesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1

1.31e-04189614d7ed96add29f219183c802895fbff519b627f635
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A SGIP1 PPP1CB SH3BP4

1.33e-04190614bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A SGIP1 PPP1CB SH3BP4

1.33e-04190614b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 KIF26B

1.33e-0419061445df8fee00f8949937863159d7aa042e72748d9b
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NPPC BCL11B KIF26B PCARE

1.33e-0419061439ab890104b4264c68a968f920f4ccd84f0bc681
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

PRR16 DENND2A COL6A3 SGIP1

1.33e-041906143a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A AMPH BLNK SH3BP4

1.33e-04190614e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 GPR157

1.36e-04191614b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DENND2A COL6A3 SGIP1 SH3PXD2A

1.36e-0419161408720998aa55131d7377c4c67c4c935865bd7d79
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DENND2A SGIP1 PPP1CB SH3BP4

1.36e-041916142fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EAF1 SIGLEC10 TNIP1 ATP2B1

1.36e-041916140b296404ebad0aadb75737f8c0462ec6934fc8bb
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.36e-041916141caf726bd07fdca389e678fc16304a6ef1790423
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 KIF26B DENND2B

1.36e-04191614107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellLV-02._Fibroblast_II|World / Chamber and Cluster_Paper

PRR16 COL6A3 NPPC SGIP1

1.36e-04191614d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 KIF26B DENND2B

1.36e-04191614bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellCOPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class

ABL1 GPR157 CCDC6 SH3BP4

1.36e-041916143480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.36e-041916143d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.39e-041926144022f208eb5db760abd0aac782a25e8ab63efc64
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 GPR157

1.39e-041926146f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 COL6A3 SGIP1 KIF26B

1.39e-0419261467e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

BLNK FNBP1L PRKAG2 SH3BP4

1.39e-04192614f7e7491426bbd6ed29a465b58bf67acb93dbb90a
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

USP36 COL6A3 BCL11B KMT2A

1.39e-0419261447646d7e4990be85072987f92bf18d52f8da752e
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 DENND2A COL6A3 SGIP1

1.39e-0419261499ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 GPR157

1.39e-04192614dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 DENND2A COL6A3 SGIP1

1.39e-041926149333aba0d04203ccccad78d82bf6359922f810a7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 SGIP1 DENND2B

1.41e-04193614c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PRR16 DENND2A COL6A3 SGIP1

1.41e-04193614b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor

DENND2A COL6A3 SGIP1 KIF26B

1.41e-04193614ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 GPR157

1.41e-04193614fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRR16 COL6A3 SGIP1 DENND2B

1.41e-041936145b602b1702283184bd3943c2a6f2290b7c37e407
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRR16 COL6A3 SGIP1 KIF26B

1.41e-041936145de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

USP36 SRRM1 PRRC2C KLF3

1.41e-041936147256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

APC FNBP1L MEX3B SSBP3-AS1

1.44e-04194614b111d10c99d7ff7eb261cd7786cd9d9a549049b1
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR16 DENND2A COL6A3 KIF26B

1.44e-0419461489b706af2b25991fc2707eb24f49ba6ff3ae01f7
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A

USP36 ATAD5 PRRC2C APC KMT2A POLL MED1

7.52e-071906174507_DN
DrugDiphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A

BCL11B ATAD5 PRRC2C APC KMT2A MED1

1.22e-051916166020_DN
DrugTiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A

MICALL1 BCL11B TTC28 ATAD5 PLA2G3 POLL

1.33e-051946162840_DN
Diseasecardiovascular disease

USP36 SRRM1 BCL11B PRKAG2 ATP2B1 NPNT

3.01e-04457596EFO_0000319
Diseasepulse pressure measurement

USP36 PRR16 COL6A3 SGIP1 TTC28 SHB CCDC6 PRKAG2 ATP2B1 NPNT

4.02e-0413925910EFO_0005763
Diseasechronic obstructive pulmonary disease

COL6A3 BCL11B SH3PXD2A SHB SRGAP2 ATF6B NPNT

4.33e-04688597EFO_0000341
DiseaseFEV/FEC ratio

COL6A3 GPR157 SH3PXD2A SHB SRGAP2 PRG4 ATP2B1 DENND2B NPNT

7.01e-041228599EFO_0004713
DiseasePrecursor B-cell lymphoblastic leukemia

ABL1 KMT2A

8.05e-0421592C1292769
Diseasebrain connectivity measurement

BCL11B KIF26B KLF3 FNBP1L PRKAG2

1.23e-03400595EFO_0005210
DiseaseBone Diseases, Developmental

NPPC ABL1

1.34e-0327592C0005941
DiseaseCarcinoma, Granular Cell

ABL1 APC KMT2A

1.64e-03116593C0205644
DiseaseAdenocarcinoma, Tubular

ABL1 APC KMT2A

1.64e-03116593C0205645
DiseaseAdenocarcinoma, Oxyphilic

ABL1 APC KMT2A

1.64e-03116593C0205642
DiseaseCarcinoma, Cribriform

ABL1 APC KMT2A

1.64e-03116593C0205643
DiseaseAdenocarcinoma, Basal Cell

ABL1 APC KMT2A

1.64e-03116593C0205641
DiseaseAdenocarcinoma

ABL1 APC KMT2A

1.64e-03116593C0001418
DiseaseAntihypertensive use measurement

SRRM1 NACA ATP2B1 NPNT

1.96e-03265594EFO_0009927

Protein segments in the cluster

PeptideGeneStartEntry
VVTSPRKVPPPSPKS

ATAD5

1211

Q96QE3
KSPSGPVKSPPLSPV

C2orf49

181

Q9BVC5
APVRPKTSPGSPKTV

PRKAG2

91

Q9UGJ0
DKFKRPTPPPSPNTQ

CCDC6

421

Q16204
PLRQKPTPTPKPSSA

LVRN

61

Q6Q4G3
SEAKPGAPPKVPRTP

NPPC

21

P23582
NPKSKPSNGLPPSPT

DENND2B

401

P78524
RAPTKPPVGPKTSPL

EAF1

146

Q96JC9
PPVGPKTSPLKDNPS

EAF1

151

Q96JC9
APTKRNSSPPPSPNK

ATP2B1

1171

P20020
QTRKGPPVPPLPKVT

AMPH

296

P49418
PPTRPVSPPQKAKEA

POLL

171

Q9UGP5
PPQTPTKTRPGSPQA

CASKIN1

776

Q8WXD9
GSPTPTSKKVPLPGP

CASKIN1

1241

Q8WXD9
SPPIKKYSPPSPGVQ

KLF3

101

P57682
TSKPTTRPTPKPTPI

NPNT

311

Q6UXI9
RPKGTPPLPPVRKSS

KIF26B

1591

Q2KJY2
GESVKPSLPSPSKPP

PCLO

291

Q9Y6V0
APVPSSPQPKLKTAP

PCLO

651

Q9Y6V0
KPTTRPTAKPTQPGP

FGFBP2

176

Q9BYJ0
PDSKATIPPNGSPKP

MNT

151

Q99583
KPRGTPKPSEGTPAP

MICALL1

351

Q8N3F8
PFTTPAPKKPGNPSR

MMACHC

251

Q9Y4U1
QSPSVPKKPGPPVLS

NUP155

991

O75694
SPSAVTSKPRKPPTP

MYO15B

921

Q96JP2
ISKRTQPPPKLPVGP

NDUFA7

31

O95182
SGRPVTPPRTANPPK

PPP1CB

311

P62140
KYPKTSPPPTPVQRR

CEFIP

111

Q711Q0
GTPPPQPPAKSKSCE

BCL11B

416

Q9C0K0
APSPLPRAGKKPTTP

BLNK

241

Q8WV28
PPPPPKTTRKQASVD

DOCK1

1846

Q14185
GKKPKPQSPPLTPTS

FNBP1L

326

Q5T0N5
GSPTKPFINPLPKPR

DENND2A

256

Q9ULE3
TKKSQPPPPQPARSA

COL6A3

3076

P12111
QPPTKSPAGTPKAPA

GPR157

301

Q5UAW9
PVAPTAQPKAPPSRT

CC2D1A

456

Q6P1N0
PATPKPQSAKPSGTP

ABL1

961

P00519
TTGPPRKEVPKTTPS

KMT2A

1311

Q03164
PVPGTPPSSKAKSPI

MED1

1211

Q15648
PPTTKRRTSPPHQPK

PCARE

1041

A6NGG8
SKPTPSITPTPGRKP

MEX3B

266

Q6ZN04
LGNSKTKSPPQPPRP

SHB

11

Q15464
VQTPQPPPKSAIKPS

SH3BP4

606

Q9P0V3
KASTPKPPGTGPVPS

RECQL4

136

O94761
RKPPTPTPEGPTVSV

PMS2P2

6

O95744
ATVPPPTAPKPQKTI

PRR16

281

Q569H4
SKKLGPISPPQPPSV

PRRC2C

2006

Q9Y520
TPKGPQPPTVSPIRS

NOP2

776

P46087
TPSSRSPAPPKPRQK

PLA2G3

291

Q9NZ20
PTTPKGTAPTTPKEP

PRG4

751

Q92954
APTTPKEPAPTTPKG

PRG4

766

Q92954
SAPKGPTPSTRPKPR

SSBP3-AS1

66

Q7Z2R9
PTPSTRPKPRTLGPQ

SSBP3-AS1

71

Q7Z2R9
SKTPPPPPQTAQTKR

APC

1436

P25054
TVPPSLRKQPSPTPG

ATF6B

661

Q99941
PSDKPAPVQKPPSSG

TNIP1

106

Q15025
PSSTPGSKKSPPEPV

TNRC18

2366

O15417
LPPKNVPATPPRTGS

SGIP1

251

Q9BQI5
QSKKATPPIPSKPPG

SH3PXD2A

941

Q5TCZ1
AKKPPAPPSPVQSQS

SRRM1

761

Q8IYB3
PPATRPKPTVFPKTN

SRGAP2

1036

O75044
NPKTPPKSPVVPRRS

TTBK2

1136

Q6IQ55
PSPVTVKPKPPARSS

TTC28

2226

Q96AY4
GPPPRAPKQVTTSLK

PRR30

376

Q53SZ7
TTSLKPRPCPGPKRP

PRR30

386

Q53SZ7
RTPLPPGAPSPESKK

SIGLEC10

621

Q96LC7
PPKLPSGSPSPKLSQ

USP36

506

Q9P275
KTPPPSQKAPSVPTI

GARIN5B

501

Q8N5Q1
KGAPTTPAATPPSPK

NACA

1146

E9PAV3